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Age-dependent loss of body wall muscle function and locomotion has been observed in 
C. elegans, however its cause has yet to be elucidated. Utilizing biochemical techniques and 
calcium imaging, we demonstrate that aberrant calcium (Ca2+) release via the ryanodine receptor 
(RyR) homologue UNC-68 contributes to age-dependent muscle weakness in C. elegans. We 
show that UNC-68 comprises a macromolecular complex bearing FKB-2, a C. elegans 
immunophilin with high homology to the stabilizing subunit calstabin (calcium channel 
stabilizing binding protein, or FKBP12). Furthermore, we demonstrate that as the nematode ages, 
UNC-68 is oxidized and depleted of FKB-2, resulting in “leaky” channels, depleted SR calcium 
stores, and a reduction in body wall muscle Ca2+ transients at baseline.  
These perturbations resulted in a motility phenotype, where fkb-2(ok3007) worms 
harboring a deletion mutation that abolishes FKB-2 binding to the UNC-68 macromolecular 
complex suffered from poor muscle performance and exercise fatigue in swimming trials. 
Moreover, pharmacological interventions inducing oxidization of UNC-68 and depletion FKB-2 
from the channel independently cause reduced body wall muscle Ca2+ transients, strongly 
suggesting that UNC-68 oxidation and FKB-2 depletion contribute to muscle function loss 
observed in aging. UNC-68 oxidation was found to correlate with lifespan, happening earlier in 
short-lived mitochondrial electron transport chain strains and later in long-lived worms. Finally, 
preventing FKB-2 depletion from the UNC-68 macromolecular complex in aged C. elegans using 
the Rycal drug S107 improved muscle Ca2+ transients. Taken together, our data implicate UNC-
68 dysfunction in the underlying mechanism of muscle function loss in C. elegans, analogous to 
observations made of RyR1 dysfunction in aged mammalian skeletal muscle, and describes for 
the first time a potential role for FKB-2 in C.elegans  physiology. 
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Age-related muscle weakness is a leading cause of morbidity in the elderly, 
resulting in frailty, loss of independence, and physical disability as a consequence of an 
increased risk of multiple falls and hip fractures(1–3). Despite a rapidly aging population 
and many decades of research into loss of muscle mass, very little is known regarding the 
underlying cellular mechanisms of age-dependent muscle weakness.  
One critical muscle protein is the ryanodine receptor (RyR), a large intracellular 
calcium release channel found in the sarcoplasmic reticulum (SR)(4–6) that acts as 
mediator in the process of excitation-contraction (E-C) coupling. Electrical stimulation of 
the plasma membrane (sarcolemma) is coupled to contractile work in the skeletal and 
cardiac muscles via a complex pathway that culminates in the release of SR Ca2+ through 
RyRs and a subsequent increase in cytoplasmic Ca2+ concentration(7). Understanding RyR 
function and regulation in aged muscle can lead to new insights on how muscle force is 
lost and novel drug therapies to maintain it, allowing people to remain physically active 
later in life.  
Previous work has determined that an underlying mechanism for the age-related 
loss of mammalian skeletal muscle function is post-translational modification 
(“remodeling”) of RyR1 (the skeletal muscle isoform), particularly oxidation(8–11). This 
results in depletion of the skeletal muscle isoform of FKBP12/calstabin1, which normally 
stabilizes the closed state of the channel preventing a pathological leak of Ca2+ and allows 
for coupled gating between RyR1 molecules(12–15). In accordance, the Marks lab 
described a role for RyR1-mediated SR Ca2+ leak in age-dependent loss of murine skeletal 
muscle function(10). Mitochondria, which are anatomically and functionally associated 
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with the SR and produce reactive oxygen species (ROS)(16,17) , also exhibited age 
dependent dysfunction due to Ca2+ overload resulting from SR Ca2+ leak via oxidized RyR1 
channels(10). The Marks lab proposed a model whereby RyR1 leak (due to age-dependent 
oxidation of the channel) causes mitochondrial Ca2+ overload, resulting in ROS production, 
further oxidation of RyR1, and exacerbation of the Ca2+leak. This lab concluded that a 
vicious cycle of chronic Ca2+mishandling was made between RyR1 and nearby 
mitochondria that contributes to age-dependent loss of muscle function. Further supporting 
this theory was the fact that targeting catalase to the mitochondria prevented RyR1 
oxidation and restored exercise capacity in old mice(18) . Importantly, the novel drug S107 
was found to restore Ca2+ transients and exercise capacity by preventing the RyR1 
mediated leak by inhibiting dissociation of the channel stabilizing subunit calstabin. Due 
to the inherent timing drawbacks in using mice for aging studies, a species that lives on 
average about two years, we were unable to further test this model in aged animals in vivo 
or in vitro. Interestingly, a decrease in locomotion and muscle degeneration has been 
observed in aged nematodes mimicking that of human sarcopenia after two weeks(19), 
providing faster access to aged striated muscle. Therefore, my thesis project utilized the 
model system C.elegans to study age-dependent muscle function loss. 
There are numerous advantages to using nematodes to study aging muscle 
function. C. elegans are a well-characterized genetics model with a short lifespan 
averaging 2-3 weeks, making it ideal for aging studies(20,21). C.elegans contains 
numerous age-related proteins with mammalian homologues, one of the best studied being 
DAF-16/FOXO. The C.elegans genome contains one homologue RyR gene called unc-
68; unc-68 (e540) null mutants exhibit locomotive defects characterized by the “unc”, or 
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“uncoordinated” phenotype(22–25). Treatment with the RyR-binding drug, ryanodine, 
induces contractile paralysis in wild-type C. elegans, but unc-68 (e540) null mutants are 
unaffected(23). Ca2+ transients triggered by action potentials (APs) in C. elegans body 
wall muscles are known to require UNC-68(25), and exposing worms to heat stress was 
recently found to cause UNC-68 dysfunction and intracellular Ca2+ leak(26). UNC-68 
shares 40% homology with human RyR1, and important functional domains are conserved 
including the PKA phosphorylation site and two EF-hand motifs(5). The C. elegans 
genome also contains eight FKB genes with varying levels of sequence identity compared 
to mammalian calstabins(27). The gene with the highest homology to the mammalian 
isoform is fkb-2, with ~60% sequence identity(28). An fkb-2 deletion mutant (ok3007) 
removes exon 1 and eliminates the first 68/108 amino acids, including conserved residues 
critical in mediating binding between mammalian RyR1 and calstabin1, which renders the 
mutant a functional null for FKB-2 (FKB-2 KO); while FKB-2 is speculated to be 
involved in muscular contraction, the function of FKB-2 in C. elegans physiology has yet 
to be elucidated(28).  
Furthermore, C. elegans exhibit age-dependent muscle deterioration and reduced 
locomotion. There is a reduction in muscle cell size associated with loss of cytoplasm and 
myofibrils, and progressive myofibril disorganization. The nematode aging phenotype is 
strikingly similar to the mammalian aging phenotype, which includes reduced skeletal 
muscle force generating capacity (akin to the progressive defects in locomotion in the 
nematode), and loss of muscle mass. However, the role of ROS in the muscle aging 
process of C. elegans remains controversial(29–31). 
 C. elegans also have many mutant strains with altered longevity, most of which 
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are mitochondrial electron transport chain (ETC) mutants; two of the best-known mutant 
strains are the long-lived clk-1 and mev-1 strains(32–40). The clk-1 worms have a loss of 
function defect in their ubiquinone synthesis pathway at Complex I: DMQ no longer 
synthesizes ubiquinone, which leads to a buildup of its precursor molecule and abolishes 
the ubiquinone pool(32–34). The clk-1 strain is speculated to have an increase in ROS 
production from Complex I, as their longer lifespan is reminiscent of other observations 
of stress-induced longevity, but its ROS status remains controversial(35,36) . The mev-1 
strain has a loss of function defect in a subunit of Complex II, which prevents the transfer 
of electrons from succinate to ubiquinone(37,38); Complex II becomes a source of ROS 
and mev-1 worms have been shown to contain elevated global ROS levels(39,40). While 
other sources of ROS could also be present, these two mutant strains should prove 
powerful tools in dissecting the role of mitochondrial ROS in age-dependent muscle 
function loss.  
 Combining our C. elegans physiological data with that of nematode genetics will 
provide a more comprehensive understanding of the aging process. By exploring the 
molecular mechanisms of age-related muscle weakness, which affects the mobility and 
independence of an increasingly aged population, my project stands to benefit society. The 
proposed work will potentially provide the foundation to clinically offset the detrimental 
effects of age-related muscle weakness through the use of S107(8–11) this is a novel drug, 
(a “Rycal”) we have published extensively on whose only known function is to prevent 
FKB-2 dissociation from RyR channels. If it can rescue muscle function by preventing 
pathogenic SR Ca2+ leak in both nematode and murine models, S107 may also improve the 
quality of life for our elderly citizens in the future. 
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Central Hypothesis: Oxidized UNC-68 channels are sufficient to cause age-






























Excitation-contraction coupling (ECC) describes how an action potential (AP) 
fired from a neuron causes muscle to contract, beginning at the neuromuscular junction in 
skeletal muscle(41). Skeletal muscle cells feature invaginations of their outer membrane 
(the sarcolemma) called T-tubules. T-tubules form a branched network, penetrating the 
myofiber at the level of the A-I junction in each mammalian muscle sarcomere, the basic 
unit of skeletal muscle tissue(42–44). T-tubules are bordered by either two terminal SR 
cisternae (referred to as a ‘triad’) in skeletal muscle or one (‘dyad’) in cardiac muscle. 
This allows for microdomains of calcium to accumulate in close proximity to the 
mitochondria and E-C coupling proteins, without activating other signaling pathways.  
Depolarization of the T-tubules via an incoming AP induces activating 
conformational changes in the E-C coupling voltage sensor, the voltage-gated Ca2+ 
channel (Cav1.1)(41), which is also known as the dihydropyridine receptor (DHPR) 45). 
These channels are tethered to RyR1 in skeletal muscle and mechanically open the 
channel, which are closed under normal conditions 5). Calcium flows out of the SR and 
cytoplasmic Ca2+ concentrations rise 10x, from 100 nM to 10 µM. RyR1 is maximally 
open at 10 µM Ca2+, where higher concentrations result in a ‘negative feedback loop’ that 
closes the channel. This rapid spike in calcium allows Ca2+ ions to displace troponin-c 
and reveal the myosin binding sites required for actin-myosin cross-bridging. The actin 
filaments “slide” past each other and cause an overall shortening of the sarcomere, or 
contraction. Once contraction has ceased, calcium is pumped back into the SR via the 
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sarcoplasmic/endoplasmic reticum Ca2+ ATPase (SERCA) and the cycle is reset until the 
next stimulus occurs(42). The amount of calcium available in the SR and the 
phosphorylation states of RyR1 and SERCA can affect the strength of contraction. RyR is 
normally closed at low cytosolic [Ca2+] (~100–200 nM); at submicromolar cytosolic 
[Ca2+] Ca2+ binds to high-affinity binding sites on RyR increasing the open probability 
(Po) of the channel(46) . Channel activity is maximal at cytosolic [Ca2+] ~10 μM while 
elevating cytosolic [Ca2+] beyond this point leads to a reduction in Po(46–48).  
 
Ryanodine Receptor (RyR1, RyR2, RyR3) 
The Ryanodine Receptor (RyR) is a homotetrameric 2.5 MDa cation channel that 
releases calcium from the endoplasmic/sarcoplasmic (ER/SR), making it a critical 
mediator of calcium signaling in excitation-contraction coupling and other calcium-
dependent signaling events in a wide range of tissues(5). It has three known isoforms, 
RyR1, RyR2, and RyR3: RyR1 is predominantly found in skeletal muscle, while RyR2 is 
the dominant isoform in cardiac muscle and neurons (RyR3 is widely expressed at low 
levels, and is the least studied isoform). They contain a transmembrane region near their 
C-terminus and a large “foot” structure at the N-terminus, where multiple regulatory 
proteins bind. Among these members of the macromolecular complex are PKA, PDE4, 
muscle A kinase anchoring protein (mAKAP), PP1, PP2A, and FKBP12/calstabin 1 (in 
skeletal muscle) or FKBP12.6/calstabin 2 (in cardiac muscle)(49). RyR channels are 
organized into a ‘checkerboard’ array within the ER/SR, where neighboring RyRs are in 
physical contact with one another. This physical and functional association allows for 
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coordinated gating, a term coined ‘coupled gating’. RyR has a conductance of 4pA when 
fully opened with Ca2+ as the charge carrier, and is a nonselective cation channel(4).  
Calstabin is one of the most important regulatory proteins in the macromolecular 
complex: it stabilizes the closed state of RyR, preventing calcium from inappropriately 
leaking through the channel(50). Posttranscriptional modifications (phosphorylation, 
oxidation, nitrosylation) deplete RyR of calstabin, resulting in higher open probabilities 
and subconductance states; this allows to calcium escape the ER/SR and form a passive 
intracellular Ca2+ leak(15). More information on Calstabin can be found in the section 




Figure 1: RyR1 in Physiological and Pathological Muscle 
Depolarization of the T-tubule membrane causes a voltage-dependent conformational 
change in Cav1.1, which activates RyR1. This leads to SR Ca2+ release and sarcomere 
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contraction, a physiological process known as E-C coupling. Intracellular signaling 
pathways activated in skeletal muscle by pathological stress causes RyR1 to undergo 
posttranslational modification (phosphorylation, oxidation, nitrosylation), which deplete 
the regulatory protein calstabin 1 from the channel. This increases RyR1 open probability 
and can result in SR Ca2+ leak, which can potentially go on to activates numerous Ca2+ -
dependent cellular damage mechanisms. AC, adenylate cyclase; note that Cav1.1 is 
mechanically associated with RyR1. (Adapted from Bellinger et al., JCI 2008) 
 
RyR Evolution 
The RyR gene is hypothesized to have derived from IP3R-B, which encoded an 
IP3R-like channel that could not bind IP3 and is replaced by RyR at the Holozoa 
clade(51). The presence of RyR and IP3R has been confirmed in animals; invertebrates 
feature one gene of each, while vertebrates have three (RyR1-3 and IP3R1-3). Both 
proteins are involved in releasing Ca2+ from intracellular stores and are macromolecular 
complexes(52), having multiple regulatory proteins associated with them and are often 
expressed in the same tissues. Ca2+ is a common second messenger, and rapid increases in 
its concentration act as a signal with many downstream effects depending on cell type. 
While calcium induced calcium release (CICR), where Ca2+ is able to activate RyR 
and/or IP3R channels and further propagate an initial Ca
2+ signal by releasing more Ca2+, 
is observed in both invertebrates and vertebrates, RyR has an additional role in 
vertebrates. Despite their similar functions, RyR has evolved unique SPRY domains that 
are absent in IP3R, one of which (SPRY2) allows RyR1 to interact with Cav1.1 in striated 
muscle(53); this couples excitation of the sarcolemma to muscle contraction and 
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eliminates dependence on extracellular Ca2+. Given that RyR is a remarkably well-
conserved protein at the mammalian level(54) despite its massive size and complex 
regulation, it would appear that independence from extracellular Ca2+ marked an 
important shift in the evolution of muscle physiology, perhaps permitting more complex 
locomotion such as sprinting that’s typically seen in higher mammals, but is absent in 
animals such as C. elegans. Additional structural differences between RyR1 and IP3R1 
can be found in the section “RyR1 Structure”.  
 
Structure of RyR1 
Due to its importance in normal and pathological muscle physiology, elucidating 
the structure of RyR was of great interest. As RyR is one of the largest proteins known, 
obtaining a crystal structure of the channel proved to be extremely difficult, with many 
researchers relying on low resolution (~28Å) structures from cryo-EM to determine the 
channel’s basic topology(55,56). Crystal structures were limited to small fragments of the 
N-terminal and phosphorylation domains, leaving much of the channel unresolved(57–
59). After an advancement in cryo-EM detector technology, the structure of RyR1 was 
resolved to 3.8-6.1Å by three independent research groups(5,60,61).  
 
The NTD (1-627) 
The N-terminal domain (NTD) consists of an A region (NTD-A, amino acid 1–
208) and a B region (NTD-B, 209–392); the C region forms a solenoid (Nsol) and 
comprises amino acids 393–627(62). This area was previously crystallized by the Van 
Petegem group and contains a number of disease relevant mutations that were speculated 
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to cause instability given the fragments sensitivity to thermal changes(57).  With the full 
RyR1 structure now available, the NTD fragments can be confidently mapped at the 
interfaces between the four monomers, which shift during the transition between the 
closed and open states(63). Additionally, NTD-B forms an interdomain interaction with 
another mutation cluster on the adjacent bridging solenoid (BrB, discussed below), 
contributing to the allosteric modulation of pore gating by stabilizing the closed 
state.(62,64) 
 
SPRY and RyR Domains (628-1656), (2735-2938) 
Three SPRY domains (628–1656) and two RYR domains (RY1&2, 850–1054; 
RY3&4, 2735–2938) are present in RyR1. Crystal structures of SPRY1 and SPRY2 were 
docked within a cluster of three SPRY domains(59,65). SPRY1 forms part of the 
calstabin1-binding site; SPRY2, which is notable for being the proposed Cav1.1-binding 
site(66), is buried under SPRY3; and SPRY3 forms contact sites with the BrB of the 
adjacent protomer. RY1&2 are repeats that group together near the ‘clamp’ region(59,67) 
, while RY3&4 are located on top of the BrB and form the PKA phosphorylation domain. 
Given their accessible location and the fact that phosphorylation of RY3&4 increases 
open probability (Po), it is hypothesized that addition of a phosphate group could help 
promote the activated or ‘downward conformation’ of the channel(63). 
 
Junctional and Bridging Solenoids (Jsol and BrB; 1657-3613) 
The junctional solenoid (Jsol) and bridging solenoid (BrB) make up ~35% of the 
protein sequence and are also known as the ‘handle’ domain (1657–2144 and 2145–3613, 
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respectively). The BrB is curled counterclockwise (as viewed from the cytosol) under the 
SPRY domains of the adjacent protomer and exhibits distinct conformations in all 
functional states. As mentioned before, BrB makes contact with SPRY3 and NTD-
B(62,64) in addition to containing a cluster of disease-causing mutations; this suggests 
that this region is important biologically as well as structurally.  
Together with the NTD, Nsol, SPRY, and RYR domains, these solenoids 
comprise the cytosolic shell: this assembly serves as the scaffold for RyR modulatory 
proteins, especially calstabin1 (FKBP12). Other modulatory proteins include: 
calmodulin, kinases (including PKA and CamKII in RyR2), anchoring proteins such as 
spinophillin and mAKAP, the phosphatases PP1 and PP2A (in RyR2), and the 
phosphodiesterase PDE4D3 (52,68,69). These regulatory proteins are further discussed in 
“RyR1 as a Macromolecular Complex” (pg 15) and allosterically control channel gating 
(pore opening and closing). Their cumulative effect regulates conformational changes in 
the pore and surrounding the TM segments(62), changing the Po of the channel.  
 
The Core Solenoid (3667–4174) 
The core solenoid is a distinct, rigid complex connecting the cytosolic shell with 
the channel pore. It forms contacts between the NTD-B of one monomer and the NTD-A 
of another(5). The core solenoid contains two interesting motifs: An EF-hand pair 
(residues 4072–4135) and a ‘thumb-and-forefinger’ (TaF) domain. The EF-hand interacts 
with the S2–S3 helices of the adjacent protomer upon channel priming and the TaF 
encircles the C-terminal domain (CTD)(62,63). Together with the CTD (discussed 
below), the core solenoid harbors the binding site for Ca2+, caffeine, and nucleotides 
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(ATP)(62,63). This allows the core solenoid to coordinate allosteric changes between the 
cytosolic shell and transmembrane portions of the RyR1 channel upon activation(63).  
 
TM Domain and CTD (4322–4956) (4957–5037) 
The C-terminal domain (CTD) is located at the cytosolic end of the S6 helix and 
is surrounded by the core solenoid, allowing changes in this region to influence both the 
cytoplasmic shell and channel pore(5). Importantly, the CTD contains the binding site for 
the three main RyR1 activators (Ca2+, caffeine, and ATP(70–72)) and this plays a crucial 
role in controlling RyR1 channel gating. Multiple RyR1 cryo-EM structures in the 
presence of different combinations of these RyR activators yielded difference maps that 
enabled the identification of the binding sites for Ca2+, ATP, and caffeine(62).  
RyR1’s 6TM domain looks similar to canonical members of the cation channel 
superfamily, forming a pinwheel structure between its first four transmembrane helices 
(S1-S4) and pore-forming helices (S5-S6) via a linker (S4-S5)(5,63). S6 is one of the 
most important helices in this region, as its long cytosolic extension (S6c) connects the 
CTD to the pore: it directly controls channel gating by transmitting the conformational 
changes caused by bound Ca2+, ATP, and caffeine within the CTD to the pore(62). The 
narrow calcium ion conduction path is also formed by S6, a short pore helix, and an 
extended segment on the luminal side of the channel pore, resembling sodium and 
potassium channels(63). However, an important difference is that RyR1 can conduct far 
more than Ca2+ ions: the channel is 11:1 selective for cations over anions and conductions 
Na+ and K+ almost 5x better than Ca2+. This lowered selectivity can be explained by the 
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observation that RyR1’s P loop does not seem to form the potassium channel signature 
structure that removes the ion hydration shell when it enters the channel path(5). 
Eight negatively charged amino acid residues from each protomer near the 
selectivity filter, and many more on the luminal loops of the TM domain, form a 
negatively charged area that serves to concentrate Ca2+ at the mouth of the pore(5). 
Additional acidic residues in the S6 helix further contribute to RyR1’s high conductance 
(~100ps) for Ca2+. The RyR1 pore is made of amino acids bearing carboxylic and 
carbonyl groups, a pattern which is echoed other Ca2+-conducting channels such as 
TRPV1(73), CavAB(74), and IP3R1(75). 
The pore aperture is formed by the S4-S5 linker and is gated by Ile4937 (the 
equivalent amino acid is Ile4868 in RyR2); this is the narrowest part of the conduction 
pathway. Despite containing all but one of the positive charges that define voltage sensor 
domains in helices S1-S4, RyR1 cannot sense changes in voltage: due to their physical 
association, Cav1.1 has taken on this role in skeletal muscle.  
 
RyR1 vs. IP3R1 
Due to their unique features, it is often useful to compare RyR to the only other 
intracellular calcium release channel in its protein family, IP3R. RyR1 and IP3R1 share 
conserved architecture in the NTD, the core solenoid, the CTD, and the TM 
domain(60,75); interestingly, they also share the S6c extension. In IP3R, this extension 
extends from the NTD vestibule to the IP3-binding domain(75). These structural 
similarities in the NTD and subdomain interfaces suggest similar functional roles for 
channel activation(76,77). Finally, superimposing the two proteins reveal a high degree 
 15 
 
of similarity in the pore region, an expected finding as both release calcium from 
intracellular stores when activated(63). 
Differences that exist between the two proteins include a conserved motif found 
in RyRs in the S2-S3 helices S2–S3, the absence of the BrB in IP3R, and the IP3R-unique 
CTD long extension of the CTD, which connects to the IP3 binding site in the NTD(75). 
It is speculated that IP3 binding will have a similar functional role as the cytoplasmic 
movements in RyR1 following activation. 
While additional information is needed to fully elucidate the functional impact of 
these conformational changes and how this relates to disease causing mutations in RyR1, 
having a more detailed view of the channel’s architecture has greatly improved our 
understanding of its biology. 
 
RyR is a Macromolecular Complex 
As a critical mediator of E-C coupling, RyR activity must be tuned to meet the 
physical demands of the organism. Channel regulation is complex and is performed by 
numerous proteins that bind to its cytosolic shell(4). The most well-known of these 
proteins include PP1, PKAcat, PDE4, mAKAP, calmodulin, and most importantly, 
FKBP12/12.6 or calstabin 1/2. The overall effect that these proteins have on channel 
activity is to stabilize its closed states and control the amount of cAMP/phosphorylation 
the channel is exposed to.  
 
PP1 and PP2A 
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PP1 and PP2A are serine/threonine phosphatases that are docked onto RyR via 
spinophillin and PR130, respectively(78). These interactions (and those of the anchoring 
protein mAKAP, below) are mediated by leucine-isoleucine zipper motifs (LZ). They 
remove phosphate groups from the channel following phosphorylation, which promotes a 
closed confirmation and reduction of channel activity(78).  
 
PKAcat, PDE4, and mAKAP 
Protein kinase A (PKA)’s catalytic subunit and phosphodiesterase 4 (PDE4) is 
targeted to RyR via muscle-A-kinase-anchoring-protein (mAKAP)(79). PKA is activated 
by the canonical β-adrenergic signaling cascade, phosphorylating RyR1 at Ser 2844 and 
RyR2 at Ser 2808. Phosphorylation causes a transient decrease in the binding affinity of 
calstabin, causing an increase in Ca2+-dependent channel activation(80–82) Reducing 
calstabin bonding has a physiological role: by increasing the likelihood that the channel 
activates during stress conditions, more calcium can be extruded from the SR and be 
available for contraction. This is part of the “fight-or-flight” mechanism, but chronic 
PKA hyperphosphorylation is maladaptive, resulting in calstabin depletion. Aberrant 
Ca2+ leak reduces SR Ca2+ store and thus, the amount of Ca2+ released upon receptor 
activation(80–82).  
PDE4 is cAMP-specific and acts as a counterbalance: it breaks down the 
messenger molecule and prevents it from further activating PKA(69). This creates a 
localized negative feedback loop for RyR2, ensuring tight regulation of phosphorylation 





Calmodulin (CaM) is a small, ubiquitously expressed calcium binding protein; it 
binds to RyR monomers at a 1:1 stoichiometry, the same ratio as calstabin. In RyR1, apo-
CaM (Ca2+ free) is a partial agonist of channel activation at nanomolar Ca2+ 
concentrations. In contrast, higher Ca2+ concentrations, Ca2+ bound CaM functions as a 
channel inhibitor(83). Unlike RyR1, CaM inhibits RyR2 channels at all Ca2+ 
concentrations in cardiac muscle(84). CaM has also been found to modulates Cav1.1 
gating in the T-tubule membrane, and calcium bound-CaM may inhibit binding between 
the C-term of the Cav1.1 α1S-subunit to RyR1(85)  
 
Calstabin1/2 (FKBP12/12.6) 
FKBP12 and FKBP12.6 are members of the immunophilin family of proteins, 
peptidylprolyl isomerases that aid in protein folding as chaperones. They belong to the 
FK-506 binding protein class, all of which are targets of the immunosuppressive drugs 
sirolimus (rapamycin) and FK-506 (tacrolimus)(86,87). In humans, treatment with FK-
506 or rapamycin blocks calcium dependent T-cell activation, as each drug forms a 
complex with FKBP binding proteins(87). Named after their molecular weights, FKBP12 
was first identified as an unknown peptide following RyR digestion with the 
endoprotease Lys-C(6). Further studies revealed the presence of a tightly bound, 12kDa 
protein that associated with RyR1 in a 1:4 molar ratio (one FKBP12 protein per RyR 
monomer, 1:1). FKBP12 (calstabin1) is abundant in skeletal muscle and associates most 
frequently to RyR1; FKBP12.6 (calstabin2) is most common in cardiac muscle and 
associates with RyR2(13).  
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It was determined that both of these immunophilins had a critical cellular 
function: stabilizing the closed state of the RyR channel. Calstabin binding increases the 
number of RyR channels with full conductance levels, decreases open probability after 
caffeine activation, and increases mean open time. Abolishing the binding between 
calstabin and RyR, resulting in subconductance states; the channel is unable to close 
properly, resulting in Ca2+ leaking out of the SR. The amino acids V2461 and P2462 are 
critical to Calstabin1-RyR1 binding, with the equivalent amino acids being I2427 and 
P2428 in RyR2. Mutating these sites on RyR reduces binding and maximal voltage-gated 
calcium release by approximately 50%.  
There are 3-4 calstabin molecules bound to RyR at all times in non-pathogenic 
states. Phosphorylation of the channel can cause calstabin to dissociate(13), resulting in 
1-2 dissociating from the channel under stress conditions: the posttranslational 
modifications of hyperphosphorylation, oxidation, and nirosylation can completely 
deplete all calstabin molecules from the channel, leading to intracellular Ca2+ leak and the 
loss of coupled gating, which requires caltabin binding. Reassociating calstabin or 
preventing its depletion pharmacologically has been shown to improve disease 
progression in many animal models and acts as a viable drug strategy.  
 
RyR1 in Disease 
Malignant Hyperthermia and Central Core Disease (MH and CCD) 
Mutations in RyR are associated with many diseases, which have been 
collectively coined “channelopathies”(88). The first channelopathy is malignant 
hyperthermia (MH), a potentially life-threatening hyperthermic reaction to anesthesia that 
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is caused by mutations in RyR1(89). Pathology is thought to develop from excessive 
muscle contraction (via anesthetic exposure), which subsequently results in acidosis and 
metabolic heat generation; patients can quickly reach core body temperatures of 43 
degrees Celsius(90). Rapid administration of dantrolene, a muscle relaxant, has greatly 
reduced mortality(91); however, prevention is made difficult as a previous family history 
of negative anesthetic reactions is often the only indication, and screening requires tissue 
from invasive muscle biopsies. It is believed that as many as 1 in 2,000-3,000 people 
could be susceptible MH given pedigree studies(92). Approximately ~200 RyR1 
mutations are associated with MH and the disease is inherited in an autosomal dominant 
fashion (93). They cluster in three distinct regions: N-terminal residues 1–614 
(corresponding to the NTD-A, NTD-B, and Nsol), central domain residues 2163–2458 
(BrB), and C-terminal residues 4136–4973 (CTD and TM) (94). One mutation (R614C in 
humans) was found to be conserved in pigs, who suffer from a similar hyperthermia 
under stressful conditions(91,95). This demonstrates that pigs are a suitable animal model 
for MH, and suggests that other species can be used to study RyR channelopathies.  
Another muscle-related disorder is associated with changes in RyR1 biology: the 
rare congenital myopathy Central Core Disease (CCD) and related myopathies are also 
linked to RyR1 mutations in the three ‘hot spot’ areas(96). While this group of diseases 
feature variable penetrance, they all present with a gradually worsening ‘core’ of inactive 
tissue within the center of muscle fibers(96). These cores are metabolically inactive, 
lacking mitochondria; patients with the most severe forms of CCD have pronounced 
muscle weakness. As CCD is sometimes co-morbid with MH susceptibility, it is thought 
that they result from similar changes in RyR1 activity(96,97).  
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Despite their similarities, there are some crucial differences between the two 
diseases: CCD does not require an anesthetic trigger to manifest and is instead present in 
patients from a young age. MH muscle biopsies to not present with the signature ‘cores’ 
that CCD and related myopathies are known for, and CCD alone does not generate 
excessive heat(98). While MH mutations tend to be found most often in the N-term and 
central ‘hot spot’ areas in RyR1, dominant CCD mutations localize in the C-term 
region(97). It is important to note however, that studies have shown these mutations 
result in gain-of-function, increasing RyR1’s sensitivity to activation. As they have 
similar effects, the mutations are often grouped together, both experimentally and in the 
literature.  
Most MH and/or CCD mutations were found to increase RyR1 activation after 
caffeine or halothane (an anesthetic) exposure(93,99,100); physiological conditions were 
maintained by transfecting recombinant mutant channels were transfected into dyspeptic 
(RyR1 KO) muscle fibers, allowing Cav1.1 to associate with and activate 
RyR1(101,102). The cumulative effect of the gain-of-function mutations is to promote 
RyR1 calcium ‘leak’: the leak is noticeable in MH only following anesthesia, whereas a 
chronic leak leads to persistent muscle weakness in CCD(103). Further evidence of a leak 
can be found in the N-terminal CCD mutations, which couples a reduction in the amount 
of Ca2+ released in response to depolarization with an increase in basal Ca2+ levels(104). 
Combined with a reduction in the SR calcium content, these results were consistent with 
leaky channels and present a potential therapeutic target.   
One interesting CCD mutation in the C-term (I4898T) abolished caffeine 
activation of RyR1 and severely reduced ryanodine binding(105). Co-expressing with 
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wild type RyR1 only partially rescued the phenotype, suggesting a more pronounced, 
gain-of-function. Unlike other mutations, myotubes with I4898T had normal resting Ca2+ 
and SR store content, but severely deficient Ca2+ release in response to 
depolarization(105). As I4898T is located in the pore, it was proposed that it reduced 
Ca2+ permeation and represents a second mechanism to explain CCD muscle weakness: 
instead of causing RyR1 to become leaky, it uncouples RyR1 from Cav1.1, preventing 
the channel from releasing Ca2+ when necessary(105). This highlights the complexity of 




RyR1 channels can contribute to disease pathogenesis without bearing a discreet 
mutation: dystrophic muscle was found to have elevated cytoplasmic calcium levels, due 
in part to post translationally modified RyR1 leaking calcium from the SR. Studies have 
shown that iNOS co-immunoprecipitates with RyR1 in dystrophic muscle samples, an 
observation that is associated with hypernitrosylation of the channel(9). As disruption of 
the dystrophin-glycoprotein complex (DGC) results in decreased nNOS expression, iNOS 
increases in an apparent case of compensation: iNOS then localizes to RyR1 channels 
and nitrosylates them, linking dystrophin disruption to RyR1 leak(9). It is important to 
note that increased cytoplasmic calcium itself could activate the channel after 
hypernitrosylation, as the channel is rendered more sensitive to calcium activation.  
Studies conducted in mdx mice (Duchenne’s muscular dystrophy model) showed 
that RyR1 underwent stress-induced remodeling via posttranslational modifications, in 
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particular nitrosylation (9). These changes caused calstabin1 to dissociate from the 
channel, resulting in an intracellular Ca2+ leak and forming a direct mechanism by which 
perturbations in RyR1 regulation can exacerbate muscle weakness in muscular 
dystrophies(9). These findings have been echoed in limb-girdle muscular dystrophy 
through the use of β-sarcoglycan-deficient mice, an established model of the 
disease(106). Again, RyR1 was excessively cysteine nitrosylated and depleted of 
calstabin1, which increased spontaneous RyR1 openings and reduced specific muscle 
force(9) Other muscular diseases caused by RyR1 dysregulation include ventilator-
induced diaphragmatic dysfunction (VIDD), where diaphragm muscle weakness occurs 
after chronic mechanical ventilation(107) and additional core myopathies.  
 
RyR1 in Age-Dependent Muscle Function Loss 
RyR1 was shown to be a key factor in age-dependent muscle function loss in 
rodents, mimicking sarcopenia. In aged mice, RyR1 was found to be oxidized, 
nitrosylated, and depleted of calstabin(10). In accordance with their RyR1 remodeling, 
24-month-old mice had reduced tetanic Ca2+ release, muscle specific force and exercise 
capacity compared to 3-6 months old mice. This effect was strikingly similar to what was 
previously observed in dystrophic mice. RyR1 complex remodeling resulted in “leaky” 
channels with increased open probability, which led to decreased SR calcium stores(10). 
Further corroborating this mechanism were six-month old, phospho-mimetic mice that 
had leaky RyR1-S2844D mutant channels, which exhibited comparable skeletal muscle 
defects(10). Treating aged mice with the Rycal S107 (described below) stabilized binding 
of calstabin1 to RyR1 and improved muscle function(10). The data from this paper 
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culminated in a “vicious cycle” hypothesis of age-dependent muscle function loss: leaky 
RyR1 channels would let calcium accumulate near adjacent mitochondria, which took in 
the additional Ca2+ and became overloaded. This would lead to the loss of mitochondrial 
membrane potential and cause the electron transport chain (ETC) to produce large 
quantities of ROS, that would then further oxidize RyR1 and perpetuate the leak over 
time (Diagram 2).  Additional studies revealed that reducing mitochondrial reactive 
oxygen species (ROS) by targeting the antioxidant enzyme catalase to the mitochondria 
themselves also increased exercise capacity and muscle function in aged mice, suggesting 
that RyR1 was oxidized by mitoROS and reducing these species could alleviate the 
symptoms of sarcopenia(18) . As aging is a complex topic and the role of ROS is 
controversial therein, further investigation was required: unfortunately, the mouse’s 
average lifespan of two years made planning new experiments difficult. Owing to the fact 
that all multicellular animals age, an animal model with a shorter lifespan and striated 
skeletal muscle could also be used to better elucidate the mechanism of age-dependent 
muscle function loss.  
 
 
Figure 2: RyR1 in Age-Dependent Muscle Function Loss 
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Sarcoplasmic Reticulum (SR) Ca2+ , due to oxidation-dependent modifications of RyR1, 
exacerbates mitochondrial dysfunction and production of reactive oxygen species (ROS). 
This causes remodeling of RyR1 and results in SR Ca2+ leak, which impairs muscle force 
production. (Adapted from Andersson et al. Cell Metabolism 2011)  
 
RyR2 in Disease 
RyR2 is the predominant cardiac muscle isoform and is critical to E-C coupling in 
the heart, which has a few differences from its skeletal muscle counterpart. The most 
noticeable point of divergence is in activation: instead of being physically coupled to 
Cav1.2 (cardiac isoform), there is space between the two proteins. This allows for 
calcium to flow through Cav1.2 and activate RyR2 through calcium induced calcium 
release (CICR)(49). While oxidation is a critical posttranslational modification for RyR1, 
RyR2 is often phosphorylated in disease(78). Cardiac muscle contains G protein–coupled 
β-adrenergic receptors (β-ARs), and in stress conditions they activate adenylyl cyclase, 
leading to cAMP production and PKA activation. PKA phosphorylates RyR2 and 
additional proteins like phospholamban, an inhibitor of SERCA, in order to increase the 
amount of calcium available for muscle contraction in the canonical ‘fight-or fight’ 
response(49,78). Unfortunately, PKA phosphorylation can overcome other regulatory 
proteins like PP2A and PDE4D3(69), leading to chronic hyperphosphorylation. This type 
of posttranslational modification is maladaptive, depleting calstabin 2 from RyR2 




RyR2 has numerous mutations; in contrast to RyR1, mutations in RyR2 are better 
dispersed throughout the protein, not localizing in three distinct regions. These mutations 
commonly cause arrhythmias: catecholaminergic polymorphic VT (CPVT)(81,109) and 
ARVD are rare, inherited cardiac disorders resulting from RyR2 mutations. While CPVT 
leads to sudden, exercised-induced death, ARVD presents with fat and/or fibrous tissue in 
the right ventricle. Both show signs of RyR2 Ca2+ leak, and similar to its skeletal muscle 
counterpart, this leak can be abolished by re-associating calstabin with the channel or 
preventing its depletion(80,110) (see Rycals section, below). Additional diseases that 
demonstrate RyR2 Ca2+ leak outside of cardiac muscle include defects in insulin 
release/glucose homeostasis(111) and neurological disorders such as PTSD(112), 
seizure(110), and Alzheimer’s(113); the Rycal S107 prevented calstabin 2 depletion in 
mice modeling these diseases(110–113).  
 
Rycals: S107  
Once it had been established that intracellular Ca2+ leak via RyRs was a main 
contributor in muscle disease pathology, the question of how to reverse or prevent its 
effects became critically important. One previously identified compound that was found 
to improve cardiac function was JTV-519. JTV-519 can inhibit Na+, Ca2+, and 
K+ currents(114,115); it was found to improve cardiac function in canine models of 
pacing-induced heart failure (HF)(116), and has a similar effect on cardiac and skeletal 
muscle function in calstabin-deficient mice(110). Although it had other channel targets 
besides RyR, JTV-516 had no effect on normal RyR gating in healthy animals, making it 
an ideal candidate for optimization(110). The Marks lab generated many derivatives of 
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the JTV-516 compound and developed a novel class of Ca2+ channel stabilizers called 
“Rycals”. Utilizing an orally available Rycal called S107, it was shown that the drug 
improves muscle force generation and exercise capacity in mice with either Duchenne’s 
muscular dystrophy or sarcopenia(9,10). S107 is protective against sudden cardiac death 
in CPVT mice, slowing post-MI HF progression and suppressing VT/ventricular 
fibrillation (VT/VF)(108,110,117). In every case, these benefits were the result of S107 
reducing pathologic SR Ca2+ leak in cardiac and skeletal muscle(9,10,117,118). Given 
these results and the plethora of diseases associated with RyRs, Rycals have the potential 
to be a powerful new treatment for a number of life-threatening muscular conditions and 
















Chapter Two: UNC-68 Intracellular Calcium Leak Contributes to Age-Dependent 
Muscle Function Loss in C. elegans 
 
C. elegans  
C.elegans is an exceptionally well described animal model with many useful 
characteristics that make it ideal for experimentation. Most live as hermaphrodites that 
are capable of laying hundreds of eggs, although males can be found rarely (1:500) or at 
an increased rate in times of environmental stress(119); this allows for both crossbreeding 
and maintenance of a modified strain, as mutations can easily be propagated throughout a 
population. They are transparent and can be readily imaged using a stereoscope or (once 
transfected with GFP) a confocal microscope, which has allowed for each of its 95 
striated muscle cells to be mapped and studied(120). In addition to the vast array of 
genetic techniques developed to manipulate the worm, it has predictable movement 
patterns and behaviors that can be tested in numerous assays. C. elegans larvae can be 
frozen for long-term storage and are easy to rear on a bed of OP-50, an E. coli derived 
bacterial strain(121). Most importantly, C. elegans has an average lifespan of only 14-21 
days, allowing for access to aged tissue faster than in other model systems and making 
them ideal for aging studies(122).   
 
Worm Striated Body-Wall Muscle 
C. elegans body-wall muscle is remarkably similar to vertebrate skeletal muscle, 
sharing important structural features and homologues of crucial proteins. Both are striated 
and contain sarcomeres, the basic functional unit of muscle. The C. elegans sarcomere 
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consists of myosin organized into thick filaments and attached to the M-line, along with 
actin-containing thin filaments associated with a structural element called the dense body, 
which is thought to be the precursor to the Z-disk. It has A and I bands, which are 
myosin-enriched and actin-enriched bands, respectively. Like mammalian skeletal 
muscle, C. elegans body-wall myocytes generate all-or-none APs that lead to Ca2+ 
release from the SR, although these APs depend on calcium flux through EGL-19 rather 
than a voltage-gated conformational change that is transmitted to UNC-68(25).  
Importantly, C. elegans contain highly conserved homologues of many proteins 
that play key roles in vertebrate muscle function.  In addition to UNC-68 (the RyR 
homologue in the worm) and FKB-2 (the closest calstabin homologue), C. elegans has 
homologues for numerous members of the aforementioned E-C coupling process like 
Cav1.1 (EGL-19)(123), IP3R (ITR-1)(124), and SERCA (SCA-1)(125);Table 2 also 
includes the percent identity and homology compared to human E-C proteins. Important 
scaffolding proteins such as dystrophin and sarcoglycans(126) are present as well, 
including actin and associated proteins (Supplemental Figure 1). Additional structural 
and assembly proteins have C. elegans homologues, further highlighting the similar 
architecture of the worm and mammalian sarcomere(120). Taken together, these 
observations suggest that the basic structural elements of skeletal muscle have been 
highly conserved throughout evolution and that similar physiological principles can be 
extended to both models.  
While striated muscle in the worm closely resembles that of vertebrates, it has 
some unique features. As previously stated, C. elegans body-wall muscle cells are 
mononucleated, and feature 95 cells in total(127). They form a monolayer and are 
 29 
 
arranged into quadrants, a pattern that extends from head to tail. There are no satellite 
cells, meaning C. elegans muscle cannot regenerate if injured(120,127). Dense bodies are 
pitched six degrees from the longitudinal axis of the worm, presumably to accommodate 
changes in muscle cell shape at the point where dense bodies are stabilized by linkage to 
the cytoskeleton(128).  One critical difference between vertebrate skeletal muscle and C. 
elegans body-wall muscle is that the latter lacks t-tubules(127), invaginations of the 
sarcolemma that are closely associated with the sarcoplasmic reticulum (SR) and allow 
for fast conduction of APs (action potentials) during excitation-contraction coupling. One 
possible theory as to why worms lack t-tubules is that the plasma membrane of body wall 
muscle cells is very close to the SR, maintaining the optimal close distance. As EGL-19 
has never been shown to be tethered to UNC-68(129) (as Cav1.1 is to RyR1 in vertebrate 
muscle (21)), this arrangement could allow extracellular calcium to enter the worm 
muscle, providing a spike in calcium concentration that can keep the animal moving: as 
C. elegans rely on movement to imbibe bacteria, this necessity could explain why severe 
loss of function mutations in EGL-19 results in embryonic lethality(123), while UNC-68 
KO worms can still move, but poorly (See UNC-68 section, below).  
 
UNC-68, C. elegans Ryanodine Receptor 
C. elegans has been used as a genetics model to study disease for years, making 
many critical discoveries. However, physiological techniques in C. elegans have lagged 
compared to other model systems due to its small size, thick cuticle, and the high skill 
required to overcome these obstacles(130). While this has limited studies in the past(19), 
new algorithms are being used to better study C. elegans behavior, and standard 
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physiological tools are now being adapted for worms, allowing us to expand on previous 
work on age-dependent muscle function loss(131,132).  
UNC-68 is encoded by the only RyR gene in C.elegans, which shares many 
similarities with its mammalian homologue: it contains over 5000 amino acids and is 
located in striated muscle SR(133). The channel is ryanodine-sensitive, where WT worms 
exposed to the alkaloid undergo partial paralysis and hypercontraction, like their 
mammalian counterparts. It shares 40% sequence identity to RyR1, with high homology 
regions spread across the protein, but especially prominent in the transmembrane domain 
and parts of the large cytosolic region(134). Importantly, UNC-68 has not been shown to 
be tethered to EGL-19, (the DHPR/Cav1.1 homologue in the worm), meaning its 
activation could instead initiated through CICR. Both EGL-19 and UNC-68 are required 
for AP-elicited elevations of intracellular Ca2+ concentration. 
UNC-68 KO strains are generated by deleting portions of the channel, rendering 
the protein nonfunctional; the most commonly used allele is r1162, which results in the 
removal of the transmembrane domain(21). UNC-68 KO worms demonstrate incomplete 
paralysis and ketamine-dependent convulsions, but are still capable of ‘uncoordinated’ 
movement, unlike the embryonic lethal EGL-19 KO phenotype(21,123). It is important to 
note that milder mutations in EGL-19 are not lethal, instead resulting in progressively 
worsening muscle loss ranging from feeble pharyngeal pumping, to egg-laying defects 
and floppy appearance(123). The most severe loss-of-function mutations show the 
distinctive embryonic lethal “Pat” (paralyzed, arrested elongation at two-fold) phenotype, 
in stark contrast to the slowly growing populations of UNC-68 KO worms(123). 
Additionally, UNC-68 KO worms have normal muscle structure and males are sterile. 
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Together, these observations indicate that UNC-68 is not required for excitation-
contraction coupling in nematodes, but rather amplifies an existing signal. Additional 
phenotypes not found in body wall muscle include a reduction in growth rate and brood 
size from defective pharyngeal pumping (feeding) and abnormal vacuoles in the terminal 
bulb of the pharynx(135). An abnormal ketamine response is observed in an UNC-68 
Ser1444 mutant, which is located in a putative protein kinase C (PKC) phosphorylation 
site(22). Presynaptic UNC-68 has been implicated in the regulation of quantal size in the 
neuromuscular junction, while disrupting channel function can decrease both the 
outgrowth and guidance of regenerating neurons(136). Additionally, neuronal UNC-68 is 
thought to be suppressed by AH-receptor interacting protein 1 (AIPR-1), as mutation in 
the latter results in calcium bursts and an increase in neurotransmitter release(137).  
Studies have suggested that exposing worms to heat stress causes UNC-68 
dysfunction and intracellular Ca2+ leak, leading to mitochondrial fragmentation and the 
breakdown of myofilaments; this process is thought to mimic rhabdomyolysis, but also 
bears striking similarity to malignant hyperthermia, providing further parallels between 
UNC-68 pathology and mammalian RyR(26). Loss-of-function mutation of the unc-68 
gene could suppress the mitochondrial dysfunction, muscle degeneration, reduced 
mobility, and decreased life span induced by heat stress. Crucially, worm strains with a 
daf-2 (-) mutant background (DAF-16/FoxO transcription factor activated), were resistant 
to the negative muscle symptoms of heat stress: they were resistance to calcium overload, 
mitochondrial fragmentation, and dysfunction(26). If unc-68 were knocked down in a 
daf-2 (-) background, it would be expected that the two would work synergistically and 
protect against heat stress, albeit with motility consequences for the worm strain. These 
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findings echo those found in mice, where Ca2+ accumulation causes mitochondrial 
damage and consequently induces muscle breakdown(10), with the trigger being heat-
damaged UNC-68. As DAF16 upregulation was protective, it suggests that oxidation was 
a key feature of UNC-68 damage following heat stress.  
 
FK-506 Binding Proteins (FKBPs) in C. elegans 
 Very little is known about the functional role of FKBP proteins in worm biology: 
eight homologues of varying molecular weights have been identified, called FKB-(1-8). 
FKB-3, FKB-4, and FKB-5 are known to have dual peptidyl prolyl cis-trans isomerase 
(PPIase) domains, signal peptides and ER retention signals (PPIase activity was found for 
FKB-3)(138). Both FKB-3 and FKB -5 are expressed in the exoskeleton-synthesizing 
hypodermis during molting and collagen synthesis cycles, while FKB-4 is expressed at a 
low level throughout development. Deletion mutants of each individual protein yielded 
no phenotypes, but combined triple and double FKB-4 and FKB-5 deletion mutants 
arrested at 12 degrees C, but developed normally at 15-25 degrees C. These cold-
sensitive mutants revealed that this set of FKBs were essential for normal nematode 
development under adverse physiological conditions(138).  
 FKB-6 is expressed from at every development stage, from embryo to adult, with 
expression peaking in the adult dorsal and ventral nerve cords(139).  It was found to play 
a  role in  synaptonemal complex (SC) assembly and is required for proper movement of 
dynein, increasing resting time between movements in double-strand break repair 
kinetics(140); two mammalian homologues, FKBP51 and FKBP52, can affect nuclear 
translocation of glucocorticoid receptor depending upon their degree of association with 
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dynein, suggesting a conserved binding interaction(141). As attenuating chromosomal 
movement in FKB-6 mutants partially restores the defects in synapsis, this suggests that 
FKB-6 plays a role in regulating dynein movement by preventing excess chromosome 
movement, allowing for proper SC assembly and homologous chromosome pairing(140).  
 As of this writing, there are currently zero publications on FKB-1, FKB-2, FKB-
7, and FKB-8: one article lists FKB C. elegans proteins with known mammalian 
homologues, but does not investigate their biological functions(27). As FKB-2 was the 


















Chapter 2 Methods 
C. elegans strains and culture conditions  
Worms were grown and maintained on standard nematode growth medium (NGM) 
plates with a layer of OP50 Escherichia coli in an incubator at 20oC, as described(119). N2 
(Bristol) and fkb-2 (ok3007) were provided by the Caenorhabditis Genetics Center 
(University of Minnesota). fkb-2(ok3007) was backcrossed six times. The transgenic strain 
expressing Pmyo-3::GCaMP2 was kindly provided by Zhao-Wen Wang, University of 
Connecticut Health Center(34). Pmyo-3::GCaMP2 was subsequently crossed into fkb-2 
(ok3007) for measurement of contraction-associated Ca2+ transients.  
 
Age synchronization 
Adult worms at the egg-laying stage were treated with alkaline hypochlorite 
solution to obtain age-synchronized populations and eggs were plated on NGM plates, as 
described(39). For experiments requiring aged worms, age-synchronized animals at the L4 
stage were collected in M9 buffer and plated on NGM plates containing 5-fluoro-2’-
deoxyuridine (FUDR, Sigma, 50 μM) to prevent egg-laying(40).  
 
Immunoprecipitation and Western Blotting 
Nematodes were grown under standard conditions. For protein biochemistry 
experiments, a procedure to crack nematodes in a solubilizing and denaturing buffer was 
adapted(41). Briefly, worms were washed and collected with M9 buffer. They were 
centrifuged for 2 minutes at 1,000 rpm three times to wash. Worms were allowed to settle 
to the bottom of the collection tube by sitting on ice for ~5 minutes. Fluid was removed 
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and the worm pellet was snap frozen with liquid nitrogen. Frozen pellets containing whole 
nematodes were rapidly thawed under running warm water. A volume of Nematode 
solubilization buffer equal to the volume of the worm pellet was added (Nematode 
solubilization buffer: 0.3% Ethanolamine, 2 mM EDTA, 1 mM PMSF in DMSO, 5 mM 
DTT, 1x protease inhibitor) and tubes were microwaved on medium (25 s for 100 μl pellet; 
time was increased for greater volumes). Lysates were then quickly drawn into a syringe 
through a 26-gauge needle and forced back through the needle into a new collection tube 
on ice. Samples were centrifuged at 1,000 rpm for 2 minutes to remove insoluble material 
and the supernatant was transferred to a new tube on ice. Lysates were snap frozen and 
stored in at -80oC.  
A mammalian anti-RyR antibody (4 μg 5029 Ab) was used to immunoprecipitate 
UNC-68 from 100 μg of nematode homogenate. Samples were incubated with the antibody 
in 0.5 ml of a modified RIPA buffer (50 mM Tris-HCl pH 7.4, 0.9% NaCl, 5.0 mM NaF, 
1.0 mM Na3VO4, 1% Triton- X100, and protease inhibitors) for 1 hour at 4°C. The 
immune complexes were incubated with protein A Sepharose beads (Sigma, St. Louis, MS) 
at 4°C for 1 hour and the beads were washed three times with buffer. Proteins were size-
fractionated by SDS-PAGE (6% for UNC-68, 15% for FKB-2) and transferred onto 
nitrocellulose membranes for 1 hour at 200 mA (SemiDry transfer blot, Bio-Rad). After 
incubation with blocking solution (LICOR Biosciences, Lincoln NE) to prevent non-
specific antibody binding, immunoblots were developed using antibodies against RyR 
(5029, 1:5000), PKAcat (Santa Cruz Biotechnology, sc-903, 1:1000), PDE4 (kindly 
provided to us by Kenneth Miller, Oklahoma Medical Research Foundation, Oklahoma 
City, Oklahoma), PP1 (sc6104, 1:1000) or an anti-calstabin antibody (Santa Cruz 1:2,500).       
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To determine channel oxidation the carbonyl groups on the protein side chains were 
derivatized to 2,4-dinitrophenylhydrazone (DNP-hydrazone) by reaction with 2,4-
dinitrophenylhydrazine (DNPH) according to manufacturers (Millipore) instructions. The 
DNP signal on immunoprecipitated UNC-68 was determined by immunoblotting with an 
anti-DNP antibody (Millipore, 1:1000). All immunoblots were developed and quantified 
using the Odyssey Infrared Imaging System (LICOR Biosystems, Lincoln, NE) and 
infrared-labeled secondary antibodies. In addition, immunoblotting and 
immunoprecipitation of the UNC-68 macromolecular complex were conducted using 
another anti-calstabin antibody (1:2000, Abcam) and the same methods as described. Blots 
were performed with the assistance of Steven Reiken, 
 
Imaging contraction-associated body wall muscle Ca2+ transients 
Spontaneous changes in body wall muscle Ca2+ were measured in nematodes 
expressing GCaMP2 by imaging fluorescence intensity using a Zeiss Axio Observer 
inverted microscope with an electron-multiplying CCD camera (Photometrics Evolve 512) 
and an LED light source (Colibri). Nematodes were partially immobilized by placing them 
individually into a 5-10 μl drop of M9 buffer, suspended between a glass slide and 
coverslip. Twenty-second videos of individual nematodes were recorded. 
 
Analyzing contraction-associated body wall muscle Ca2+ transients 
Contraction-associated body wall muscle Ca2+ transients were analyzed using an 
Interactive Data Language (IDL)-based image quantification software that was developed 
for this purpose in the Marks laboratory. For each twenty-second video, signals from the 
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body wall muscles in nematodes expressing GCaMP2 fluorescence were analyzed using 
an edge-detection algorithm from each frame as "line-scan" images with the nematode 
perimeter on the y-axis and time (s) on the x-axis(24, 42). These images were then 
quantified based on the average of the peak Ca2+ fluorescence signal on the worm muscle 
wall; these experiments were adapted from previous studies in the Marks lab(142). 
 
Drug treatments 
To pharmacologically deplete FKB-2 from UNC-68 nematodes were treated for 15 
minutes with 15 μM and 50 μM rapamycin and FK506, respectively. To re-associate FKB-
2 and UNC-68 in aged nematodes, treatment was with 10 μM S107 for 3-5 hours. 
Nematodes were grown in standard conditions, age synchronized as described, washed and 
collected with M9 buffer, centrifuged for 2 minutes at 1,000 rpm three times to wash. 
Worms were allowed to settle to the bottom of the collection tube by sitting on ice for ~5 
minutes. Fluid was removed and the worm pellet was gently resuspended in M9 containing 
the appropriate drug concentration and gently rocked on a shaker at room temperature for 
the denoted time periods. Collection tubes were centrifuged for 2 minutes at 1,000 rpm and 
M9 containing drug was removed and replaced with M9. Biochemistry or Ca2+ 
measurements were then conducted as previously described(15). These experiments were 
adapted from previous studies in the Marks lab(142).  
 
Measuring SR Ca2+ Stores using Caffeine Activation 
Age-synchronized GCaMP2::WT and GCaMP2::FKB-2 KO were grown on 
NGM plates at 20 degrees Celsius; they were separated from their progeny and left 
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undisturbed until Day 5. Individual worms were placed in a drop of M9 on a coverslip. 
The liquid was carefully wicked away using KIMTECH wipes until only a sliver of 
moisture surrounded the worm. The worm was quickly glued down to the coverslip using 
a tiny drop of DermaWorm applied to the head and tail of the worm, before the worm 
desiccated. 80 µl of M9 buffer was added immediately afterwards to polymerize the glue. 
Once the worm was secure, a clean lateral cut to the immediate tail region was made 
using a 20G 1 ½ needle (technique adapted from Wang ZW et al. Neuron 2011). An 
additional 170 µl of M9 buffer was applied for a total of 250 µl. The completed 
preparation was placed on the platform of a Zeiss confocal microscope; after 1 min at 
baseline, 25 mM of caffeine was added equivolume to the M9 solution. The resulting 
body-wall transients were recorded for 1 min. 
 
Swimming Behavior Studies   
Standard M9 buffer was mixed with 2% agar and poured into 96 well plate wells 
to create a planar surface for analyzing worm swimming behavior. Once the mixture had 
polymerized, approximately 180 µl of M9 was pipetted on top of the agar bed and age -
synchronized worms from one of two groups (WT or FKB-2 KO) were placed 
individually into each well. To elucidate differences in exercise fatigue, worms were 
allowed to swim freely in M9 buffer for 2 hours; swimming bends and curls(132) were 
recorded by eye for 1 min. Representative videos were taken of each group and 






Worms were age-synchronized and plated on FuDR plates at the young adult 
stage using the aforementioned technique. Worms were allowed to grow unperturbed 
until the end of their natural lifespan. Worms were scored as dead if they did not react to 
three gentle prods to the head and tail region; worms that bagged or exploded were 





































Chapter 2 Results: 
 
UNC-68 comprises a macromolecular complex  
We hypothesized that UNC-68 is regulated by a macromolecular complex, similar 
to that of mammalian RyRs. To test this hypothesis, lysates were prepared from populations 
of freeze-cracked wild type C. elegans and UNC-68 was immunoprecipitated using 
mammalian anti-RyR antibody (5029). The immunoprecipitates were immunoblotted to 
detect UNC-68, the catalytic subunit of protein kinase A (PKAcat), protein phosphatase 1 
(PP1), FKB-2, and phosphodiesterase 4 (PDE-4), using mammalian anti-RyR, anti-PKA, 
anti-PP1, anti-Calstabin, and anti-PDE-4 antibodies. The previously published C. elegans 
anti-PDE-4(45) was used to detect PDE-4 on the channel. Our data show that UNC-68 
comprises a macromolecular complex similar to that found in the mammalian muscle that 
includes PKAcat, PP1, PDE-4 and FKB-2. UNC-68 was depleted of FKB-2 in the fkb-2 
(ok3007) null mutant (Figure 3A); without FKB-2, UNC-68 and the rest of the 
macromolecular complex could not be immunoprecipitated from worm microsomes when 
using an anti-FKBP antibody (Figure 3B); quantification of the band intensity from 
triplicate experiments can be found in Figure 3C. 
 41 
 
             
  
 
Figure 3: UNC-68 is a macromolecular complex; UNC-68 (A) and FKB-2 (B), 
respectively, were immunoprecipitated and immunoblotted using anti-RyR, anti-





























































































protein phosphatase 1 (PP1), and anti-Calstabin (FKBP) antibodies in murine skeletal 
sarcoplasmic reticulum preparations (Sk SR), wild type populations of C. elegans (WT) 
and populations of fkb-2 (ok3007). Representative immunoblots from triplicate 
experiments. (C) Quantification of the average band intensity from triplicate experiments: 
band intensity was defined as the ratio of each complex member’s expression over its 
corresponding RyR/UNC-68’s expression. For simplicity, RyR = UNC-68 in this context.  
 
fkb-2 deficiency causes accelerated aging and reduced body wall muscle Ca2+ transients 
RyR1 channels are oxidized, leaky and Ca2+ transients are reduced in aged 
mammalian skeletal muscle(14). Mirroring this scenario, C. elegans exhibited an age-
dependent decline in body wall muscle peak Ca2+ transients from day 3 to day 15 post-
hatching (Figure 4A).  
 Genetic FKB-2 deficiency caused acceleration of the age-dependent reduction in 
body wall muscle Ca2+ transients (Figure 4A) with peak Ca2+ in fkb-2(ok3007) worms at 
day 7 being significantly lower than that of wild type of the same age(142).  
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Figure 4: Age-dependent reduction in Ca2+ transients is accelerated in fkb-2 (ok3007) 
relative to WT; (A) Ca2+ transients in age-synchronized populations of wild type and fkb-
2 (ok3007) nematodes; (B) Representative trace from GCaMP2 WT worms; gray box 
denotes peak fluorescence from worm muscle during contraction.  
 
 
FKB-2 depletion from UNC-68 causes reduced body wall muscle Ca2+ transients 
To investigate the individual effect of the age-dependent modification, FKB-2 
dissociation from UNC-68, independent of the other confounding variables involved in 
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aging, we introduced pharmacological interventions mimicking the aged state in young 
adult nematodes. FKB-2 was competed off from the UNC-68 macromolecular complex 
using rapamycin or FK506. Both rapamycin and FK-506 bind to calstabin and compete it 
off from RyR channels resulting in leaky channels and release of SR Ca2+ in the resting 
state(49-51). Rapamycin-FKBP12 inhibits mTOR and FK506 inhibits calcineurin, 
indicating that their non-RyR related actions do not account for the observed SR Ca2+ leak.  
Ca2+ transients were measured in partially immobilized transgenic nematodes 
expressing the genetically encoded Ca2+ indicator, Pmyo-3::GCaMP2, in the body wall 
muscle cells(34, 52) (Figure 5A-B). Pharmacologic depletion of FKB-2 from UNC-68 by 
rapamycin or FK506 treatment caused reduced body wall muscle Ca2+ transients in wild 
type C. elegans (Figure 5A). When FKB-2 was genetically depleted from the UNC-68 
complex as in the fkb-2 (ok3007) nematodes, treatment with rapamycin or FK506 had no 
effect on the Ca2+ transients (Figure 5B). These data suggest that rendering UNC-68 
channels leaky by removing FKB-2 depletes SR Ca2+ resulting in reduced Ca2+ transients 





             
Figure 5: FKB-2 depletion from UNC-68 causes defective Ca2+ handling; (A and B) 
Contraction-associated Ca2+ transients measured in young age-synchronized WT and fkb-
2 (ok3007), respectively, populations were treated for 15-20 minutes with 15 μM and 50 
μM rapamycin (Rap) and FK506, respectively. Statistics were calculated using a one-way 
ANOVA, Bonferroni’s multiple comparisons test; ** = p <.001, *** = p <.0001. WT N = 
18, 21, 22; FKB-2 KO N =  26, 18, 20. NS = Non-significance C) Image of representative 




Loss of FKB-2 results in depleted SR Ca2+ stores compared to age-matched controls  
Continuous Ca2+ leak from UNC-68 would be expected to result in depleted SR 
Ca2+ stores. In order to determine if UNC-68 was leaky, we utilized a common technique 
in the mammalian RyR literature: in brief, an activating concentration of caffeine is used 
to fully open the RyR channel, leading to a rapid release of calcium from the SR into the 
cytoplasm. This increase is approximated using a previously targeted, florescent calcium 
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dye or indicator. The genetically encoded calcium indicator chosen was GCaMP2, which 
was under the Pmyo3 promoter(143). When calcium entered the cytosol of the body wall 
muscle cells, a fluorescent transient could be observed and quantified. Caffeine was applied 
to Day 5 GCaMP2::WT cut worms (Figure 6A) and the amount of fluorescence given off 
by the GCaMP2 was measured. The majority of GCaMP2::WT worms demonstrated a 
strong Ca2+ transient within 15 seconds of caffeine administration, while most 
GCaMP2::FKB-2 KO worms failed to produce a response (Figure 6B), suggesting that 
their SR Ca2+ stores were too low to illicit one. Interestingly, GCaMP2::KO worms  were 
observed as having very high background fluorescence, which may indicate an increase in 
cytosolic Ca2+ from passive UNC-68 leak.  
                          
Figure 6: Ca2+ transients are reduced in FKB-2 KO worms following caffeine 
activation. A) Representative image of caffeine activated calcium transient in GCaMP2 
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WT; arrow denotes peak fluorescence in body-wall muscle B) Fluorescence intensity 
following caffeine activation in age-matched GCaMP2::WT versus GCaMP2::FKB-2 KO 
worms at Day 5. p = .004, Student’s t-test; WT n=15, FKB-2 KO n=15.  
 
 
UNC-68 channel dysfunction reduces muscle function in exercise trials  
In mammals, calstabin regulation of RyR is tightly coupled to β-adrenergic 
signaling and it is known that calstabin KO mice must undergo exercise stress before 
demonstrating a distinct muscle phenotype. Our method of inducing exercise stress in the 
worm was to place it in M9 buffer and observe it swimming, a well-curated behavior(44). 
Swimming has been shown to have a greater energy cost than crawling. Animals that swim 
continuously for at least 90 min consume muscle fat supplies and exhibit post-swim 
locomotory fatigue, both of which are recovered within 1 hour of exercise cessation(132). 
By using an extended time trial of 2 hours, the worm would fatigue and mimic the exercise 
stress endured by its mammalian counterpart. Our data clearly shows a defect in FKB-2 
KO swimming behavior over the course of its lifespan when compared to the WT. FKB-2 
KO worms had decreased bending activity earlier in life, beginning at Day 5, and an 
increased proportion of curling, a sign of fatigue (Figure 7). Throughout midlife, the FKB-
2 KO worms lag significantly behind their age-matched WT counterparts, suggestive of 
decreased muscle function. Taken together with our Ca2+ transient data, the observed 





Figure 7: FKB-2 KO worms suffer from exercise fatigue earlier than age-matched 
WT controls A) Graph showing number of bends recorded for WT vs FKB-2 KO worms 
at six distinct ages (Day 3, 5, 7, 9, 12, 15). (B) Number of curling events were calculated 
as a percentage of the overall motility (curls/bends). N = ~60 worms per group, with the 
exception of Day 15 (as fewer worms were alive at this time point). Day 15 = ~40 




Depletion of FKB-2 from UNC-68 is an underlying mechanism of age-dependent decrease 




The small molecule Rycal S107 inhibits SR Ca2+ leak by reducing the stress-
induced depletion of calstabin from the RyR channel complex(46, 53). Here, we show that 
treatment with S107 (10 μM) for 3-5 hours(142) re-associated FKB-2 with UNC-68 in aged 
nematodes (Figure 8A). Furthermore, treatment with S107 improved peak Ca2+ in an FKB-
2 dependent manner, as demonstrated by the fact that treating the FKB-2 KO worms results 





Figure 8: The RyR-stabilizing drug S107 increases body wall muscle Ca2+ transients 
in aged C. elegans; (A) Aged (Day 15) GCaMP2::WT worms were treated for 3-5hrs with 
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10µM S107 an contraction-associated Ca2+ transients were measured (adapted from 
Umanskaya, 2015). B) The fkb-2 (ok3007) strain was treated with S107 as indicated and 
served as a negative control. * = p < .05, calculated via Student’s t-test C) The chemical 
structure of S107 (adapted from Bellinger et al., 2008).  
 
 
Lifespan of FKB-2 KO Worms is Comparable to WT 
Age-matched groups were reared on FuDR plates end of the L4 stage and left 
unperturbed. Blinded studies reveal that there is not a statistically significant difference 
between WT and FKB-2 KO worm lifespans; however, a consistent and slight decrease 
was noted for the FKB-2 worms compared to their WT counterparts in all experiments, 
suggesting that including additional variables such as locomotion into the assay might yield 






Figure 9: WT and FKB-2 KO worms have similar lifespans at baseline  
WT worms and FKB-2 KO worms were reared on plates containing 50 μM FuDR and left 
to live out their natural lifespan. Worms were scored for death every day and events such 
as bagging and vulval prolapse were censored. Survival was estimated using Kaplan-Meier 
statistics, p = .793; N = 36 for WT group, N= 35 for FKB-2 KO. This representative curve 



















Chapter 3: Oxidative Remodeling of UNC-68 is Age-Dependent 
Aging is known to have a stochastic element: individual animals of the same 
genotype that have been raised in identical environmental conditions will often die at 
different times, a consistent observation in worms(19). Factors that can alter an organism’s 
lifespan include cellular stress pathways (in particular, the Insulin/insulin-like growth 
factor signaling cascade), nutrition sensing, dietary restriction, energy generation, protein 
biosynthesis, and cellular detoxification via glutathione-S-transferases. In total, over 400 
genes have been observed to alter C. elegans longevity and that of other organisms; while 
many of the identified proteins are conserved, a consolidated theory of aging has been 
elusive and the question of why species have different lifespans despite similar cellular 
machinery remains prominent.  
Harman’s Free Radical Theory of Aging is one of the oldest hypotheses to propose 
a unified mechanism to explain why organisms age, stating that the accumulation of 
reactive oxygen species (ROS) damage proteins and organelles over time(29). The role of 
oxidation and ROS in C. elegans aging is controversial, with laboratories producing 
contradictory results in regards to the amount of global ROS present in a given 
strain(35,36). In worms, some of this confusion stems from the indirect techniques used to 
measure oxidation in worms, which rely on lipid peroxidation (36) or unblinded lifespan 
assays(144), and a lack of reliable biomarkers for worm aging. While there is little dispute 
that oxidative damage is present in age-dependent diseases, the question of whether 
increased ROS causes aging, or is merely a byproduct or biomarker, still remains. 
Antioxidants have not increased lifespan as the theory has implied, an observation that is 
well-curated in nematodes(144–147). Additionally, some groups have reported unique 
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signaling roles for ROS in angiogenesis, suggesting that it could act as a signaling molecule 
rather than being a sign of damage(148). To better clarify the role of oxidation in aging, it 
is useful to focus on some of the best described worm proteins involved in oxidation and 
lifespan: SOD and DAF-16.  
  
Super Oxide Dismutase (SOD) in C. elegans 
 Super oxide dismutase (SOD) is considered to be the first line of antioxidant 
protection against ROS, as it performs dismutation on superoxide produced by the 
mitochondrial electron transfer chain (ETC), forming molecular oxygen and hydrogen 
peroxide(156). Mammals have three isoforms of SOD, while C. elegans have six isoforms 
of SOD: SOD-1 and SOD-5 are cytosolic, SOD-2 and SOD-3 are mitochondrial, and the 
last two are both forms of SOD-4 and predicted to be extracellular(149–151). It would be 
expected that knocking out the sod genes in C. elegans would result in increased global 
ROS levels and a shortened lifespan due to oxidative damage, while increases in expression 
would be protective and extend lifespan. Surprisingly, knocking out one or both of SOD-2 
and SOD-3 did not reduce lifespan in WT worms(152,153), increasing lifespan in one study 
despite increased ROS levels(154). These findings are not conserved in mammals, with 
mice showing greater sensitivity to mitochondrial SOD loss and SOD-2/3 KO mice having 
early post-natal death(155–157). 
There is more consensus between species when the cytosolic isoforms SOD-1 and 
SOD-3 are deleted in worms and mice: both species show a decrease in lifespan, although 
other groups have found no change in nematodes(153,154,156), showing that the effect in 
mice is more severe. The overexpression of cytosolic SOD-1 in C. elegans was shown to 
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prolong lifespan, as expected(158), and overexpressing SOD-2 in mice led to paraquat-
induced oxidative stress resistance (but normal lifespan)(157). It is important to note that 
the lifespan extension was found to be dependent on a well-recognized longevity gene 
product, the DAF-16/FOXO3A transcription factor, showing that while there may be 
differences in how species handle ROS, certain key elements are conserved(153,159,160). 
 
DAF-2 and DAF-16 (Insulin/Insulin-like Growth Factor 1 Receptor and FOXO 
Transcription Factor Family) 
DAF-16 is the only worm protein with homology to the mammalian FOXO 
transcription family and has well-established, beneficial effects on worm lifespan(161–
163). In a DAF-2 (Insulin/IGF-1 Receptor homologue) knockdown background, where 
DAF-16 is less inhibited, worms have a lifespan average of 40 days, well above the 14-21 
day standard(161); this effect is dependent solely on DAF-16(164), as increasing the 
expression of its isoforms can overcome normal DAF-2 levels(165). The fact that DAF-16 
consistently and dramatically increases worm lifespan in a DAF-2 (-) background or when 
overexpressed suggests that its downstream targets are involved in decreasing ROS 
levels(166), and have a critical role in aging. FOXO transcription factors support oxidative 
stress resistance via its downstream targets(167,168), suggesting that endogenous 
protection from ROS is still a critical aspect in determining an animal’s lifespan; further 
study is required to elucidate the complex effect of ROS in aging.  
One possible explanation for why ROS level reduction via antioxidants fails to 
prolonging lifespan is that the location of oxidative damage is a crucial factor: most 
methods decrease global ROS levels(144), which may be inefficient in addressing localized 
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spikes of ROS in mitochondria or nearby mediator proteins. Recent advances have led to 
targeted methods of using redox sensitive GFPs to better approximate oxidation in discrete 
parts of the worm(169). With new techniques and tools at researchers’ disposal, a clearer 
picture of oxidation’s role in aging should be forthcoming. 
 
Mitochondrial ETC Mutant Strains CLK-1 and MEV-1 
 One strategy to better clarify the role of ROS in aging is to focus on what proteins 
are being damaged and where: RyR oxidation has been a consistent feature of pathology 
in many muscle diseases, and intracellular calcium leak from the channel has been 
observed in affected humans and mice. The ‘vicious cycle’ hypothesis (Figure 2) suggests 
that mitochondria are overloaded with Ca2+ from nearby leaky RyR1 during aging and 
increase their ROS production, suggesting that mitochondrial ROS could be an important 
aspect of a unified ‘aging mechanism’. This is corroborated by the fact that in mutants 
worms where the DAF-16/FOXO transcription factor is activated, there is resistance to 
calcium overload, mitochondrial fragmentation, and dysfunction(26). As many 
mitochondrial mutations have been generated in C. elegans, investigating those that have 
extended or attenuated lifespans could help clarify the role of ROS in aging. 
Two mutant mitochondrial ETC strains, the Complex I mutant CLK-1 and the 
Complex II mutant MEV-1, have been researched extensively and have altered lifespans, 
making them ideal for aging studies(32–39). CLK-1 worms contain a Complex I-associated 
mutation where they cannot synthesize their own ubiquinone (UQ), a redox active lipid 
that accepts and transfers electrons from Complex I or II to Complex III in the electron 
transport chain (ETC). As it is unable to make its own UQ, CLK-1 worms accumulate high 
 56 
 
amounts of its precursor, 5-demethoxyubiquinone-9 or DMQ(9) (note that the CLK-1 
strain can imbibe a bacterial form of UQ from their food source)(33,170). This inhibits 
Complex I-dependent oxidative phosphorylation, while Complex II-III activity is normal. 
Although reports are mixed as to the amount of ROS present in these animals(33,36,171), 
there is a clear consensus that the reduction in Complex I activity has resulted in a long-
lived worm; considering that Complex I usually produces ROS, this suggests that ROS 
levels near the mitochondria are either the same as WT (if compensation occurs) or 
decreased. In contrast, MEV-1 contains a Complex II (succinate dehydrogenase) 
cytochrome B560 mutation(34,38,39); this prevents electron transfer from succinate to 
fumarate and causes ROS production, which is not a normal byproduct of Complex II 
activity. Likewise, MEV-1 worms are known to have both increased ROS levels and 
decreased lifespan, averaging only 9 days(38).  
 If UNC-68 is oxidized in the short-lived mutant (MEV-1) earlier than WT and 
CLK-1 worms, this could reveal mitoROS as the source of UNC-68 oxidation in age-
dependent muscle function loss, further clarifying the mechanism and corroborating 
previous findings. If an initial pathway for age-dependent muscle function loss is found, 
UNC-68 and its associated protein could act as a biomarker of muscle damage, leading to 
additional, previously unstudied proteins being tested for oxidative damage and 








Chapter 3 Methods:  
C. elegans strains and culture conditions  
Worms were grown and maintained on standard nematode growth medium (NGM) 
plates with a layer of OP50 Escherichia coli in an incubator at 20oC, as described(119). N2 
(Bristol) and fkb-2 (ok3007) were provided by the Caenorhabditis Genetics Center 
(University of Minnesota). fkb-2(ok3007) was backcrossed six times. The transgenic strain 
expressing Pmyo-3::GCaMP2 was kindly provided by Zhao-Wen Wang, University of 
Connecticut Health Center(34). Pmyo-3::GCaMP2 was subsequently crossed into fkb-2 
(ok3007) for measurement of contraction-associated Ca2+ transients.  
 
Drug treatments 
To pharmacologically deplete FKB-2 from UNC-68 nematodes were treated for 15 
minutes with 15 μM and 50 μM rapamycin and FK506, respectively. To re-associate FKB-
2 and UNC-68 in aged nematodes, treatment was with 10 μM S107 for 3-5 hours. 
Nematodes were grown in standard conditions, and were asynchronous for studies 
involving GCaMP2 worms; samples were washed and collected with M9 buffer, 
centrifuged for 2 minutes at 1,000 rpm three times to wash. Worms were allowed to settle 
to the bottom of the collection tube by sitting on ice for ~5 minutes. Fluid was removed 
and the worm pellet was gently resuspended in M9 containing the appropriate drug 
concentration and gently rocked on a shaker at room temperature for the denoted time 
periods. Collection tubes were centrifuged for 2 minutes at 1,000 rpm and M9 containing 
drug was removed and replaced with M9. Biochemistry or Ca2+ measurements were then 
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conducted as previously described(15). These experiments have been adapted from 
previous studies conducted in the Marks lab(142). 
 
Immunoprecipitation and Western Blotting 
Nematodes were grown under standard conditions. For protein biochemistry 
experiments, a procedure to crack nematodes in a solubilizing and denaturing buffer was 
adapted(41). Briefly, worms were washed and collected with M9 buffer. They were 
centrifuged for 2 minutes at 1,000 rpm three times to wash. Worms were allowed to settle 
to the bottom of the collection tube by sitting on ice for ~5 minutes. Fluid was removed 
and the worm pellet was snap frozen with liquid nitrogen. Frozen pellets containing whole 
nematodes were rapidly thawed under running warm water. A volume of Nematode 
solubilization buffer equal to the volume of the worm pellet was added (Nematode 
solubilization buffer: 0.3% Ethanolamine, 2 mM EDTA, 1 mM PMSF in DMSO, 5 mM 
DTT, 1x protease inhibitor) and tubes were microwaved on medium (25 s for 100 μl pellet; 
time was increased for greater volumes). Lysates were then quickly drawn into a syringe 
through a 26-gauge needle and forced back through the needle into a new collection tube 
on ice. Samples were centrifuged at 1,000 rpm for 2 minutes to remove insoluble material 
and the supernatant was transferred to a new tube on ice. Lysates were snap frozen and 
stored in at -80oC.  
A mammalian anti-RyR antibody (4 μg 5029 Ab) was used to immunoprecipitate 
UNC-68 from 100 μg of nematode homogenate. Samples were incubated with the antibody 
in 0.5 ml of a modified RIPA buffer (50 mM Tris-HCl pH 7.4, 0.9% NaCl, 5.0 mM NaF, 
1.0 mM Na3VO4, 1% Triton- X100, and protease inhibitors) for 1 hour at 4°C. The 
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immune complexes were incubated with protein A Sepharose beads (Sigma, St. Louis, MS) 
at 4°C for 1 hour and the beads were washed three times with buffer. Proteins were size-
fractionated by SDS-PAGE (6% for UNC-68, 15% for FKB-2) and transferred onto 
nitrocellulose membranes for 1 hour at 200 mA (SemiDry transfer blot, Bio-Rad). After 
incubation with blocking solution (LICOR Biosciences, Lincoln NE) to prevent non-
specific antibody binding, immunoblots were developed. 
To determine channel oxidation the carbonyl groups on the protein side chains were 
derivatized to 2,4-dinitrophenylhydrazone (DNP-hydrazone) by reaction with 2,4-
dinitrophenylhydrazine (DNPH) according to manufacturers (Millipore) instructions. The 
DNP signal on immunoprecipitated UNC-68 was determined by immunoblotting with an 
anti-DNP antibody (Millipore, 1:1000). All immunoblots were developed and quantified 
using the Odyssey Infrared Imaging System (LICOR Biosystems, Lincoln, NE) and 
infrared-labeled secondary antibodies. In addition, immunoblotting and 
immunoprecipitation of the UNC-68 macromolecular complex were conducted using 











Chapter 3 Results:  
Age-dependent oxidative remodeling of UNC-68 
RyR1 oxidation has been linked to SR Ca2+ leak and impaired muscle function 
during extreme exercise and in heart failure and muscular dystrophies(22, 46, 47). 
Furthermore, we have previously reported that oxidation of RyR1 and the subsequent 
intracellular Ca2+ leak are underlying mechanisms of age-related loss of skeletal muscle 
specific force (force normalized to the cross sectional area of muscle)(14). UNC-68 was 
depleted of FKB-2, and oxidized in an age-dependent manner(48). Similarly, we have now 
shown that UNC-68 was significantly more oxidized at day 7 in fkb-2(ok3007) worms 
compared to wild type (Figure 10), suggesting age-dependent muscle function loss is 
happening at an accelerated rate in the FKB-2 KO worms when compared to WT. 





Figure 10: Age-dependent oxidative remodeling of UNC-68 
UNC-68 was immunoprecipitated from age-synchronized populations of WT and FKB-2 
KO (KO) nematodes, and immunoblotted using anti-RyR, anti-Calstabin and DNP (marker 
of oxidation) antibodies. Immunoblot is representative of duplicate experiments and ‘Days’ 
signify time from hatching. Quantification of band intensity ratios for oxidation 
(DNP/RyR) and FKBP/calstabin binding (FKBP/RyR) is provided.  
 
S107 prevents FKB-2 depletion, but not UNC-68 oxidation, in aged WT worms 
The Rycal S107 has previously been shown to prevent calstabin depletion in 
mammals, but does not reduce channel oxidation. To determine if this was also the case in 
C. elegans, we incubated Day 15 WT worms with 50 µM S107 for 5 hrs and 
immunoprecipitated UNC-68 from both control and treated worm lysates(142). UNC-68 
channels from treated aged worms showed a significant amount of FKB-2 association, 
despite having similar levels of oxidation as their untreated counterparts (Figure 11); this 
suggest that the S107 binding site is conserved in nematodes and still has the beneficial 
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Figure 11: S107 prevents FKB-2 depletion in aged WT worms 
UNC-68 was immunoprecipitated and immunoblotted with anti-RyR, anti-Calstabin 
(Santa Cruz) and DNP (marker of oxidation) in aged nematodes with S107 treatment as 
previously described.   
 
 
Increased UNC-68 oxidation correlates with lifespan shortening in MEV-1 worms 
 Previous studies have suggested that RyR oxidation in muscle pathology is in part 
due to nearby mitochondria becoming overloaded with calcium, leading to an increase in 
mitochondrial ROS; to test if the mitochondria could potentially be a source of UNC-68 
oxidation, we immunoprecipitated UNC-68 from two worm strains that are known to have 
mitochondrial ETC defects, but have very different lifespans: CLK-1, a long-lived 
Complex I-associated mutant, and MEV-1, a short-lived Complex II mutant. MEV-1 
worms have elevated ROS levels, and would be expected to have oxidated UNC-68 
channels; our results demonstrate that this process starts much earlier than in WT and CLK-
1 samples, while the worm is still at L4/young adult stage (Figure 12). In contrast, CLK-1 
worms had delayed UNC-68 channel oxidation, suggesting that UNC-68 modification 
correlates with age-dependent muscle function loss and overall lifespan (Figure 13). These 
results also further implicate mitochondrial ROS as the oxidation source of the UNC-68 
channel, although other ROS sources may also contribute. 
 64 
 
      
 
Figure 12: UNC-68 oxidation correlates with lifespan in mitochondrial ETC 
mutants  
UNC-68 was immunoprecipitated from age-synchronized populations of WT, CLK-1 
(long-lived), and MEV-1 (short-lived) worms; all three groups were immunoblotted using 
anti-RyR, anti-Calstabin and DNP (marker of oxidation) antibodies. Timepoints were Days 
2, 7, and 15 from hatching, with the exception of the MEV-1 group; their lifespan average 
is ~ 9 days total. Immunoblot represents duplicate experiments; quantification of band 




My thesis work shows that the C. elegans intracellular Ca2+ release channel UNC-
68 comprises a macromolecular complex and thus this is highly conserved throughout 
evolution from nematodes to humans. Binding of the mammalian homolog of the 
stabilizing subunit calstabin, FKB-2, to the UNC-68 channel is required to prevent a 
pathological leak of intracellular Ca2+, as is the case in mammalian muscle(14). Aged C. 
elegans have reduced Ca2+ transients, and their UNC-68 channels are oxidized and depleted 
of FKB-2. Each of these post-translational modifications of UNC-68 likely contribute to 
the aging phenotype, as pharmacologically depleting UNC-68 of FKB-2 and oxidizing the 
channel in young nematodes each independently yield the observed aging phenotype, 
reduce contraction-associated Ca2+ transients. Genetic FKBP-2 deficiency causes an 
accelerated aging phenotype; Ca2+ transients are reduced in younger populations of fkb-2 
(ok3007) nematodes and UNC-68 is oxidized at an earlier time point in these mutants 
relative to wild type. Additionally, UNC-68 oxidation correlated with lifespan in 
mitochondrial ETC mutant worms, suggesting that mitoROS is the source of oxidation and 
perturbations in its levels could affect lifespan. Treating aged wild type nematodes with 
the RyR-stabilizing drug, S107, re-associates FKB-2 with UNC-68 and increases the Ca2+ 
transients, indicating that UNC-68 dysfunction is likely an underlying mechanism of age-
dependent decrease in Ca2+ transients in C. elegans body wall muscle.  
 
UNC-68 regulation via FKB-2  
In nematodes the UNC-68 macromolecular complex is comprised of a similar array 
of regulatory subunits as the mammalian RyR1 channels: a phosphodiesterase PDE-4, a 
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protein kinase PKA, a protein phosphatase PP1, and the immunophilin, FKB-2. My data 
suggest that FKB-2 stabilizes the closed state of UNC-68 in C. elegans and prevents a 
pathological leak of intracellular Ca2+ similar to its role in the mammalian RyR1 complex. 
The evolutionary conservation of the RyR channel complex and age-dependent effects on 
the channel indicate that C. elegans are an excellent model for studying age-associated loss 
of muscle function. Furthermore, the finding that S107 can improve the muscle Ca2+ 
transient in age nematodes, a marker for improved muscle function, suggests that C. 
elegans might be a useful model organism for screening for pharmaceutical agents to 
improve muscle function in aging. 
  
Oxidation of UNC-68 in aged C. elegans 
C. elegans exhibit an aging muscle phenotype similar to human sarcopenia. This is 
characterized by declined locomotion, reduction in muscle cell size associated with loss of 
cytoplasm and myofibrils and progressive myofibril disorganization(4). However specific 
body wall muscle proteins involved in the C. elegans aging phenotype have not been 
determined. Here, we show that UNC-68 is oxidized in aged nematodes and depleted of 
the channel-stabilizing protein, FKB-2. Our group has reported that similar remodeling of 
the RyR1 in skeletal muscle from aged mice(10) and in murine models for Muscular 
Dystrophies(9) is indicative of intracellular Ca2+ leak and reduced muscle specific force. 
We show here that Ca2+ transients are reduced in aged C. elegans body wall muscle. 
Furthermore, treating aged C. elegans with the RyR stabilizing drug, S107, re-associates 
FKB-2 with the channel and increases body wall muscle Ca2+ transients. These data 
indicate that remodeling of the UNC-68 complex plays a key role in age-dependent loss of 
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muscle function in nematodes.  
I present here for the first time an association between age-dependent oxidation of 
UNC-68 and reduction in Ca2+ transients in aged nematodes. Though the oxidative stress 
theory of aging was first proposed in 1956(29), there is still substantial controversy 
surrounding the role of ROS in aging; for example, deletion or overexpression of the ROS 
detoxification enzyme superoxide dismutase (SOD) has little effect on life span in C. 
elegans(31,154). However, loss of the gene, sesn-1, which encodes sestrin, an 
evolutionarily conserved protein that is required for regenerating hyperoxidized forms of 
peroxiredoxins and for ROS clearance, causes reduced lifespan(172). Furthermore, ROS 
levels measured in vivo in C. elegans increase with age(169).  
It would be interesting to know if the increased UNC-68 oxidation and subsequent 
reduction in body wall muscle Ca2+ transients are the result of globally increased ROS 
levels or increased ROS levels in UNC-68-surrounding microdomains, especially when we 
consider the CLK-1 and MEV-1 experiment. We have previously shown that inducing RyR 
leak in enzymatically dissociated skeletal muscle cells causes increased mitochondrial 
membrane potential and mitochondrial ROS production(106). Based on these data we have 
proposed a model in which RyR1 leak (due to age-dependent oxidation of the channel) 
causes mitochondrial Ca2+ overload resulting in ROS production and further oxidation of 
RyR1 and exacerbation of the SR Ca2+ leak creating a vicious cycle between RyR1 and 
mitochondria that contributes to age-dependent loss of muscle function(10) C. elegans 
would be an excellent model in which to test this model further in aged organisms in vivo.  
My thesis work also demonstrates that the putative null mutant, fkb-2(ok3007), 
prevents FKB-2 from co-immunoprecipitating with UNC-68. The aging phenotype that I 
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characterized in wild type nematodes (biochemically modified UNC-68 and reduced Ca2+ 
transients) is accelerated in fkb-2(ok3007). There are eight FKBs that are homologous to 
mammalian calstabin in the C. elegans genome; FKB-1 and FKB-8 both have ~50% 
sequence identity to calstabin. Further studies could elucidate the possibility that in the 
absence of FKB-2 another FKB may stabilize UNC-68, in particular the aforementioned 
FKB-8 (its gene is in close proximity to that of FKB-2 on chromosome 2, and FKB-1 (most 
similar to FKB-2 in terms of molecular weight). However, this appears not to be the case 
since the aging phenotype is accelerated in the absence of FKB-2. Another key question is 
why UNC-68 becomes oxidized within two weeks, whereas the same post-translational 
modification requires two years in mice and 80 years in humans (173). Given the incredible 
conservation of RyR and other members of the complex (Figure 1), it is feasible that genetic 
screens in organisms such as C. elegans and Drosophila will yield additional crucial 
mediators that are common among species and explain disparities in lifespan.  
Further studies branching from my project should focus on determining the role of 
mitochondrial ROS in aged worm muscle function loss; while preliminary results suggest 
that nearby damaged mitochondria are the oxidation source causing UNC-68 pathology, 
there are other potential sources to consider, especially NADPH oxidases (NOX). A key 
implication that has come from this project is that age-dependent muscle function loss 
follows a similar mechanism regardless of species; namely, important muscle proteins are 
damaged via accumulated ROS and lose function over time. Identifying these additional 
proteins that altered by oxidation can help answer the critical question of why species vary 
so wildly in regards to lifespan, despite aging having many evolutionarily conserved parts 






































Supplemental Figure 1: Actin Filament and Associated Proteins Shared Between 
Vertebrates and C. elegans  
Proteins in parentheses are the vertebrate equivalent to the worm proteins listed. 
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